Rho-kinase 1 (ROCK1) has been implicated in diverse metabolic functions throughout the body, with promising evidence identifying ROCK1 as a therapeutic target in diabetes and obesity. The gene discussed is ROCK1; the disease is obesity due to melanocortin 4 receptor deficiency.